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Abstract
Hosts can be infected with multiple herpesviruses, known as superinfection; however, superinfection of cells is rare due to
the phenomenon known as superinfection inhibition. It is believed that dual infection of cells occurs in nature, based on
studies examining genetic exchange between homologous alphaherpesviruses in the host, but to date, this has not been
directly shown in a natural model. In this report, gallid herpesvirus 2 (GaHV-2), better known as Marek’s disease virus (MDV),
was used in its natural host, the chicken, to determine whether two homologous alphaherpesviruses can infect the same
cells in vivo. MDV shares close similarities with the human alphaherpesvirus, varicella zoster virus (VZV), with respect to
replication in the skin and exit from the host. Recombinant MDVs were generated that express either the enhanced GFP
(eGFP) or monomeric RFP (mRFP) fused to the UL47 (VP13/14) herpesvirus tegument protein. These viruses exhibited no
alteration in pathogenic potential and expressed abundant UL47-eGFP or -mRFP in feather follicle epithelial cells in vivo.
Using laser scanning confocal microscopy, it was evident that these two similar, but distinguishable, viruses were able to
replicate within the same cells of their natural host. Evidence of superinfection inhibition was also observed. These results
have important implications for two reasons. First, these results show that during natural infection, both dual infection of
cells and superinfection inhibition can co-occur at the cellular level. Secondly, vaccination against MDV with homologous
alphaherpesvirus like attenuated GaHV-2, or non-oncogenic GaHV-3 or meleagrid herpesvirus (MeHV-1) has driven the virus
to greater virulence and these results implicate the potential for genetic exchange between homologous avian
alphaherpesviruses that could drive increased virulence. Because the live attenuated varicella vaccine is currently being
administered to children, who in turn could be superinfected by wild-type VZV, this could potentiate recombination events
of VZV as well.
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Introduction
Marek’s disease (MD) is caused by gallid herpesvirus 2 (GaHV-2),
better known as MD virus (MDV). MDV is a member of the
Mardivirus genus in the subfamily of Alphaherpesvirinae [1]. Symp-
toms of MD include immune suppression, neurologic signs such as
paralysis and ataxia, and the development of lymphoproliferative
disease in chickens characterized by solid tumors in the viscera and
other organs. Natural infection begins through inhalation of virus,
after which MDV is taken to the lymphoid organs and primary
cytolytic replication in B and then T lymphocytes ensues [2,3].
Following lytic infection, latency is established mainly in activated
CD4
+ T cells, which may be transformed into highly proliferative
T cell lymphomas, depending on the genotype of the infected
chicken and strain of virus. Irrespective of the transformation
event, infection of feather follicle epithelial (FFE) cells in the skin
by migrating infected lymphocytes leads to the production of
infectious particles that are shed into the environment, providing a
continuous source of infectious virus. The lifecycle of MDV is
similar to a human alphaherpesvirus, varicella zoster virus (VZV,
human herpesvirus 3, HHV-3), that causes varicella, commonly called
chicken pox, during primary infection and herpes zoster,
commonly referred to as shingles, during reactivation from
latency. Both viruses enter the host through the respiratory tract,
initially infect epithelial cells and then lymphocytes, which
transport virus to the skin where infectious virus is produced in
epithelial skin cells and shed into the environment [2,4].
Intraspecific recombination of alphaherpesviruses, that is,
recombination between alphaherpesviruses within the same
subfamily, occurs frequently in vivo [5]. It has been documented
that inoculation of two attenuated or mutant strains of
alphaherpesviruses into animals can result in production of
virulent virus, as has been shown for herpes simplex virus 1
(HSV-1, human herpesvirus 1, HHV-1) [6,7], pseudorabies virus
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[15], and infectious laryngotracheitis virus (ILTV, gallid herpesvirus
1, GaHV-1) [16]. Intraspecific recombination is dependent on at
least three requisites. First, there has to be significant homology
between the two viruses, at the genetic level, so that recombination
could occur. Second, both viruses need to infect the same host and
third, both viruses need to infect the same cell for recombination
to proceed. Without this, recombination between two viruses
would be highly unlikely. It has been shown that dual infection of
cells by PRV occurs within the animal. Banfield et al. showed that
two attenuated PRV strains, one expressing enhanced GFP (eGFP)
and the other expressing monomeric RFP (mRFP), could infect
the same neurons when injected into the anterior chambers of
separate rat eyes [17]. Dual infection of PRV in rat neurons was
also recently shown using mutant viruses expressing fluorescent
proteins [18]. To date, there are no published studies directly
analyzing dual infection of cells by two homologous alphaherpes-
viruses within a natural host.
Superinfection inhibition, whereby infection of a cell by one
virus inhibits dual infection by a second virus, has been described
for many viruses of bacteria, plants, and animals [19–28]. Banfield
et al. used primary cultures of rat dorsal root ganglia (DRG) and
showed that dual infection of cells with two PRVs occurred with
high frequency (,100%) when the primary rat DRG cultures were
infected simultaneously (coinfection) with both viruses [17]. When
one virus was inoculated followed by the second (superinfection)
$4 h later, dual infection of the DRG was very infrequent (,1%).
Thus, their data strongly suggested a significant amount of
superinfection inhibition occurs during infection of primary rat
DRG neurons in vitro. To date, it has not been demonstrated that
superinfection inhibition occurred in vivo during infection with
homologous herpesviruses.
In the case of MDV, dual infection of cells by two different
viruses is of particular importance because since the 1960’s, MD
has largely been controlled using homologous avirulent vaccines.
These vaccines generally prevent the development of MDV-
induced tumors and disease, but do not prevent superinfection
with pathogenic MDV [29]. Non-oncogenic turkey herpesvirus
(HVT, meleagrid herpesvirus 1, MeHV-1), non-oncogenic chicken
herpesvirus 3 (gallid herpesvirus 3, GaHV-3), and attenuated MDV
(attGaHV-2) have been used during the last four decades in
vaccination programs against MD. Modified live vaccines are
typically administered to newly hatched chicks or in ovo at 18 to 19
days of embryonation, but are exposed to challenge virus almost
immediately in commercial settings [30]. It is widely accepted that
the use of highly homologous vaccines against MD have ultimately
led to increasing virulence of pathogenic MDV strains [31]. The
long history of non-sterilizing immunity induced by MD vaccines,
the increasing virulence of MDV due to vaccination, and prior
evidence of intraspecific genetic exchange within strains of the
HSV, PRV, BoHV-1, and ILTV alphaherpesviruses in the host
are troublesome. Thus far, there is no evidence showing that
exchange of genetic material between wild-type MDV and MD-
vaccine strains occurs in nature; however, this has been mostly due
to a limitation in the molecular tools needed for such studies. We
now have efficient tools to generate virulent and attenuated
recombinant (r)MDV that express fluorescent proteins for visual
detection in vivo, without leaving genetic scars in the genome or
altering pathogenesis, and importantly, a natural alphaherpes-
virus-host model in which the results are direct and not dependent
on the use of ‘‘host-adapted’’ strains that can complicate
interpretation of data. The question of whether cells can be dually
infected during natural alphaherpesvirus infection is significant
since the recent introduction of the first effective vaccine against a
human alphaherpesvirus, VZV [32]. The long history of non-
sterilizing vaccination against MD in chickens, taken together with
the similar virus life cycles that MDV and VZV use to enter and
exit the host, highlight the importance of understanding whether
homologous viruses can regularly infect the same cells in a natural
host.
A two-step Red-mediated recombination strategy was utilized in
which the UL47 (VP13/14) tegument protein of MDV was tagged
with either eGFP or mRFP in virulent and attenuated rMDVs.
These rMDVs were generated to determine, through direct visual
examination, whether two similar, but distinguishable, alphaher-
pesviruses can dually infect the same cells in the animal. For
clarity, the term ‘‘coinfection’’ is used in this report to describe
simultaneous infection of chickens with two rMDVs, ‘‘superinfec-
tion’’ to describe infection of chickens with two rMDVs at different
times (7 and 14 days between inoculations), and ‘‘dual infection’’
to describe infection of individual cells with two rMDVs. In two
superinfection experiments performed, replication of the second
virus within FFE cells of chickens was rarely observed. However,
in coinfected chickens, dual infection and replication of both
viruses was clearly observed in individual cells, irrespective of the
virulence of the virus. There was also visual evidence that strongly
suggested superinfection inhibition occurs at the cellular level in
the host. These data conclusively show that two similar
alphaherpesviruses can infect the same cells in vivo, potentiating
the exchange of genetic material, while also showing that
superinfection inhibition can co-occur. How these two, seemingly
opposing events, can co-occur is discussed.
Results
Generation and in vitro Growth of vUL47-eGFP and -
mRFP
Recently, fully virulent fluorescent rMDV was generated by
fusing eGFP to the C terminus of the UL47 (VP13/14) tegument
protein [33]. This virus showed no reduced pathogenicity and
expression of the UL47-eGFP protein was abundant in the FFE
cells in the skin during in vivo infection. This strategy was utilized to
generate a red virus that could be distinguished from the green
virus in coinfection and superinfection studies. To do this, mRFP
was fused to the C terminus of the UL47 in three rMDV clones
using previously described Red recombination techniques [34,35].
Figure 1 shows a schematic representation of the rMDVs
generated for this report and Table 1 shows the history of each
virus. To generate fully virulent virus, mRFP was fused to the C
terminus of UL47 in the parental clone (rUL47-mRFP), as was
done previously with eGFP (rUL47-eGFP). Also generated were
two viruses previously characterized as attenuated rMDV due the
deletion of both copies of RLORF4 [36] or mutation of the viral
telomerase RNA (vTR) template sequence [37]. Both mutant
viruses were found to replicate in chickens, but at reduced capacity
compared to the highly virulent parental viruses.
Following the generation of the rMDV bacterial artificial
chromosome (BAC) clones and reconstitution of virus in primary
chicken cells, the in vitro growth properties of the rMDVs were
evaluated using plaque area assays. As was previously shown for
vUL47-eGFP [33], vUL47-mRFP replicated in a manner
indistinguishable from vParental (Fig. S1). Deletion of both copies
of RLORF4 (vDRLORF4) induced significantly greater plaque
areas compared to vParental, consistent with previous results [36],
and fusing mRFP to UL47 (vDRLORF4-47mRFP) did not affect
this. vAU5 and vAU5-47mRFP generated plaques similar to
vParental, which was expected from previous results [37]. These
data show that fusing mRFP to the UL47 tegument protein did
Dual Infection + Superinfection Inhibition In Vivo
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37428not affect in vitro growth of rMDVs, similar to the UL47-eGFP
fusion protein.
In vitro Expression of UL47-eGFP and UL47-mRFP in rMDV
Next, reconstituted viruses were evaluated for UL47-eGFP and
UL47-mRFP expression in chicken kidney cells (CKC) cultures.
Figure S2 shows expression of UL47-eGFP in vUL47-eGFP and
UL47-mRFP in vUL47-mRFP, vDRLORF4-47mRFP, and
vAU5-47mRFP in contrast to overall MDV protein expression.
As was previously described during the generation of vUL47-
eGFP [33], expression of UL47-mRFP was low in most cells
infected with only a few select cells expressing high levels of UL47-
mRFP (Fig. S2). The parental virus (vParental) had no detectable
UL47-eGFP or UL47-mRFP.
Figure 1. Generation of UL47-eGFP and UL47-mRFP fusion proteins in rMDV. Shown for each clone is the MDV genome depicting the
locations of the terminal repeat long (TRL) and short (TRS), internal repeat long (IRL) and short (IRS), and unique long (UL) and short (US) regions. The
position and orientation of the UL47 gene with respect to adjacent genes within the UL are shown. The fluorescent proteins eGFP and mRFP were
fused to the C terminus of the UL47 tegument protein in four different BAC clones to generate rUL47-eGFP and rUL47-mRFP (A), rDRLORF4-47mRFP
(B), and rAU5-47mRFP (C) using the previously described BAC clones for rRB-1B [51], rRB-1B-DRLOR4 [36], and rAU5 vTR [37]. Only genes within the
TRL are shown in the figure for simplicity, though the second copy of each gene within the IRL was also altered so that both copies of RLORF4 were
deleted or the template sequence of both vTR copies were mutated in each clone.
doi:10.1371/journal.pone.0037428.g001
Table 1. Viruses used in this report.
Name
a Originating clone (ref)
b Overall Modifications (reference)
c
vParental pRB-1B (1232) [51] None
vUL47-eGFP pRB-1B (1232) [51] eGFP fused to C terminus of UL47 [33]
vUL47-mRFP pRB-1B (1232) [51] mRFP fused to C terminus of UL47
vDRLORF4 pRB-1B (1232) [51] Both copies of RLORF4 deleted [36]
vDRLORF4-47mRFP DRLORF4 in pRB-1B [36] Both copies of RLORF4 deleted and mRFP fused to the C terminus of UL47
vAU5 vTR pRB-1B (1232) [51] Both vTR template sequences mutated [37]
vAU5-47mRFP vTR AU5mut in pRB-1B [37] Both vTR template sequences mutated and mRFP fused to the C terminus of UL47
aDesignated name of virus.
bOriginating bacterial artificial chromosome clone used in which the fluorescent protein was fused to UL47 and its original publication.
cFinal history of modifications in the recombinant virus and the reference for viruses previously used.
doi:10.1371/journal.pone.0037428.t001
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Chickens (n=18 to 20 per group) were inoculated with vUL47-
eGFP, vUL47-mRFP, vDRLORF4-47mRFP, or vAU5-47mRFP
at 7 days of age and evaluated for 8 weeks for signs of clinical MD,
mainly characterized by wasting, paralysis, and gross T cell
tumors, from 3 to 7 weeks post-infection (p.i.). vUL47-eGFP had
previously been tested for disease induction [33]. In .90% of
animals infected with vUL47-eGFP or vUL47-mRFP, clinical
signs of MD developed, and following gross examination, tumors
were observed and the percent tumor incidence determined (Fig.
S3). Consistent with previous reports, deletion of RLORF4 led to
severely reduced virulence [36] and mutation of the template area
of vTR was completely non-oncogenic [37]. These results confirm
that fusing mRFP to UL47 did not alter each rMDVs’
pathogenesis in vivo and that both DRLORF4-47mRFP and
vAU5-47mRFP maintained their attenuated characteristics.
Confirmation of UL47-eGFP and -mRFP in FFE Cells of the
Chicken
Figure 2 shows representative feather follicles infected with
rMDVs expressing fluorescent proteins 21 days p.i. All four
rMDVs expressed abundant UL47-eGFP or –mRFP in FFE cells
examined, relative to the early lytic protein pp38 that is expressed
predominantly during lytic replication [38]. Consistent with
previous work, differential expression of the late UL47-eGFP or
UL47-mRFP compared to early lytic pp38 was observed [33].
These results confirm the abundant expression of UL47 in FFE
cells in vivo, regardless of the fluorescent protein fused to its C
terminus.
Dual Infection of FFE Cells During Coinfection with Two
Highly Virulent rMDV
To address the question of whether two highly virulent rMDVs
can infect the same FFE cells, chickens were inoculated with an
equal titer [1,000 plaque-forming units (PFU) each] of vUL47-
eGFP and -mRFP (n=4), or 2,000 PFU of vUL47-eGFP (n=2) or
2,000 PFU of vUL47-mRFP (n=2) individually, in 7 day old
chickens (Fig. S4A). Twenty-eight days p.i., the feather follicles
were examined for replication of each virus using fluorescence
microscopy.
The overall number of infected follicles and areas in which
coinfection of feather follicles and dual infection of FFE cells were
observed are summarized in Table 2. In chickens infected with
each virus individually, 40.9% and 50.0% of the follicles examined
were positive for UL47-eGFP and -mRFP, respectively. In the four
coinfected chickens, all chickens were positive for infected follicles;
however, only vUL47-mRFP appeared to be present in feather
follicles of one of these birds. Intriguingly, one chicken had three
follicles positive for vUL47-eGFP, nine follicles positive for
vUL47-mRFP, and two areas within two follicles that appeared
to be dually infected with both viruses (see below).
Next, dual infection was examined during superinfection with
two virulent rMDVs. In this experiment (Fig. S4B), twenty 7 day
old chickens were inoculated with 2,000 PFU of vUL47-mRFP
and after 7 or 14 days, ten of those chickens were inoculated with
an equal titer of vUL47-eGFP. An additional chicken was
inoculated with only vUL47-eGFP as a control. At 21 and 28
days after the first inoculation, skins were collected from five
chickens for each group and infection of FFE cells with each virus
was evaluated using fluorescence microscopy. Interestingly, for all
superinfected chickens examined, only expression of UL47-mRFP
could be observed, indicating that only vUL47-mRFP was
effectively replicating in the feather follicles (Table S1). As a
positive control for vUL47-eGFP replication, the control chicken
inoculated with only this virus had 37.5% follicles positive for
vUL47-eGFP replication, indicating the fitness of vUL47-eGFP
could not explain its lack of replication in FFE cells in
superinfected chickens.
Dual Infection of FFE Cells During Coinfection with
Attenuated and Virulent rMDV
Next, attenuated and virulent rMDVs were used to examine
dual infection of cells during coinfection and superinfection of
chickens. For superinfection, chickens were inoculated with
2,000 PFU of vDRLORF4-47mRFP or vAU5-47mRFP at 7 days
of age, and then superinfected with 2,000 PFU of virulent vUL47-
eGFP 7 or 14 days later (Fig. S4C). Replication of each virus in
FFE cells was then examined at 7, 14, or 21 days after the second
inoculation. Again, during superinfection, only the first inoculated
virus could be observed replicating in the feather follicles
examined in almost all of the chickens (Table S2). In one chicken
infected with vAU5-47mRFP then superinfected with vUL47-
eGFP, only vUL47-eGFP was evident in the follicles tested.
Interestingly, even in chickens with little to no active replication in
the FFE cells of attenuated vAU5-47mRFP, superinfection with
vUL47-eGFP was not seen. The control chicken inoculated with
only vUL47-eGFP was positive for virus replication in 59.2% of
the follicle again confirming the lack of vUL47-eGFP replication
in FFE cells of superinfected chickens was not due to the fitness of
the virus.
In a fourth experiment, dual infection was evaluated during
coinfection with attenuated and virulent rMDVs (Fig. S4D). In this
experiment, vAU5-47mRFP was not used since few follicles
appeared to be infected in the previous experiment. In chickens
infected with both vDRLORF4-47mRFP and vUL47-eGFP,
coinfection of feather follicles and dual infection of FFE cells
was more readily apparent than in the first experiment. Table 3
summarizes these results. At 21 days after the second inoculation,
10.0% of follicles examined were coinfected and of those
coinfected follicles, a total of six areas were clearly infected with
both viruses. After 28 days following the second inoculation,
22.1% of follicles were coinfected and dual infection of FFE cells
was also clearly observed.
Visual Summary of Coinfection of Feather Follicles,
Superinfection Inhibition, and Dual Infection of FFE Cells
Figure 3 shows a summary of representative follicles infected
with two different rMDVs at low magnifications using fluorescence
microscopy. Figure 3A shows two representative fields of feather
follicles transversely cut through the follicles at 625, Figure 3B
shows a representative feather follicle sectioned longitudinally
down the follicle at 625, and Figure 3C shows the subcutaneous
portion of a feather follicle plucked from a coinfected chicken at
65. In some areas of the follicles, only one virus is replicating,
indicated by expression of UL47-eGFP or –mRFP alone, while in
some areas, dual infection with both viruses is evident (indicated
with an asterisk).
Since fluorescence microscopy shows full sample illumination, it
was possible that areas in which it appeared that both viruses were
infecting the same areas and cells could actually be in different
focal planes; therefore, laser scanning confocal microscopy
(LSCM) was used to derive Z-stack images. Figure 4 shows
representative examples of coinfected feather follicles and dually
infected FFE cells during coinfection experiments. Figure 4A
shows coinfection of a feather follicle where there is no overlap of
replication of each virus in the infected cells. Interestingly, in some
Dual Infection + Superinfection Inhibition In Vivo
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cells within the area showed replication of the second virus with no
overlap (Fig. 3A, lower panel). Figure 5 highlights these areas.
It was also observed that FFE cells could be dually infected with
both viruses. This is shown in Figure 4B in which both viruses are
replicating within the same cell as indicated by the merging of
green and red to make yellow in the Z-stacks shown. Figure 6
shows a single Z-stack image of a dually infected cell. In this Z-
stack, a 3–4 cells are seen replicating both red and green viruses
(indicated with an asterisk). This image is one Z-stack from
multiple Z-stacks shown in Figure S5. These data conclusively
show that two very similar alphaherpesviruses can infect the same
cells in vivo in a natural virus-host model.
Discussion
It has been previously shown that cells can be infected by two
alphaherpesviruses using highly modified viruses in unnatural host
models. However, the question still remained whether this occurs
in a natural virus-host system. This report utilized the natural
herpesvirus model of MDV in chickens to conclusively show,
through visualization of fluorescent protein expression by two
different rMDVs during in vivo infection, that both viruses can
Figure 2. Expression of UL47-eGFP and UL47-mRFP by rMDVs in vivo. Skin/feather tissues were collected from vUL47-eGFP-, vUL47-mRFP-,
vDRLORF4-47mRFP, and vAU5-47mRFP-infected chickens at 21 days p.i. Tissues were sectioned transversely through the feather follicle and FFE cells
infected with rMDVs were stained for the pp38 early lytic MDV protein and nuclei (blue) as described in the materials and methods and examined
using the Axio Imager M1 system at6200. Some cells can be seen that express only pp38 or UL47-eGFP/mRFP, while others express both (merging
green and red = yellow). Feather follicles (FF) and FFE cells are indicated.
doi:10.1371/journal.pone.0037428.g002
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number of reasons. For one, this study is the first report directly
showing that dual infection with two alphaherpesviruses actively
replicating within the same cells occurs in a natural virus-host
model, while within the same host, superinfection inhibition can
co-occur. Secondly, the fact that chickens are vaccinated against
MD with homologous avian alphaherpesviruses that can actively
replicate within the same cells in the chicken could potentially lead
to exchange of genetic material that could alter virulence of the
virus. Thirdly, though there is no direct evidence for dual infection
of human skin cells with different VZV strains in vivo, recombi-
nation between wild-type and vaccine viruses has been reported
[39]. These results show direct evidence of dual infection of skin
cells by two similar, but distinguishable, alphaherpesvirus that
could potentiate exchange of genetic material between virulent
and vaccine strains.
The evidence for exchange of genetic elements between
different homologous alphaherpesviruses suggests that dual
infection of single cells must occur in nature, but until now, it
had not been demonstrated that this occurs in a natural virus-host
model. It has been shown that rat neurons can be infected with
two different PRVs using the well-established rat model for PRV
neurovirulence. Banfield et al. showed that two attenuated PRV
strains, one expressing eGFP and the other expressing mRFP,
could infect the same neurons when injected into the anterior
chambers of different eyes of rats [17]. Recently, this model was
used in intricate transneuronal tracing studies that confirmed dual
infection of individual neurons [18]. In both of these studies, the
PRV strains used were highly modified from wild-type viruses and
the experiments were performed in unnatural hosts. Members of
the Suidae (true pigs) are the only natural hosts for PRV, although
the virus can infect numerous other mammals under experimental
conditions [40]. It is suspected that dual infection of cells in pigs
occurs since, it has been shown that recombination of PRV
vaccines can lead to new strains [12,13]. Similar evidence of
recombination between vaccine and pathogenic strains of ILTV
(GaHV-1) in chickens has been documented [16], as well as
between two mutant BoHV-1 strains in calves [15]. However, in all
previous studies in the natural host, it was never directly
demonstrated that genetic exchange or complementation occurred
through dual infection of individual cells with two viruses. The
data in this report conclusively show that two, actively replicating
alphaherpesviruses, can infect the same cells during coinfection in
the natural host (Fig. 3, 4, 6, S5).
Though dual infection of individual cells by two rMDVs was
clearly evident, it was noteworthy that there also appeared, based
on visual observation, to be superinfection inhibition occurring at
the cellular level in vivo (Fig. 3A, 4A, and 5). Superinfection
inhibition, also known as superinfection resistance, has been
widely studied in vitro [17,19–28], including alphaherpesviruses.
Banfield et al. [17] used primary rat dorsal root ganglia (DRG)
cultures and showed that two different PRVs were able to infect
the same DRG in vitro, but this only occurred with high frequency
(,100%) when the primary rat DRG cultures were infected
simultaneously (coinfection) with both viruses. When one virus was
inoculated followed by the second $4 h later (superinfection), dual
infection of the DRG was very infrequent (,1%). Thus, their data
strongly suggested a significant amount of superinfection inhibition
occurs during PRV infection of primary rat DRG neurons in vitro.
Similar results were observed when examining recombination
between two distinguishable BoHV-1 viruses in Madin-Darby
bovine kidney cells in vitro [41]. In this study, only simultaneous or
superinfection within 4 h led to production of recombinant BoHV-
1, in which recombination between the two viruses occurred with
Table 2. Coinfection with virulent viruses (Experiment 1).
Group
a Analysis (days p.i.)
b Follicles (n)
c Green
d Red
e Coinfection follicle
f Dual infection cell
g
vUL47-eGFP 28 10 3 0 0 0
1 2 600 0
% Infected: 40.9% 0.0% 0.0% Total: 0
vUL47-mRFP 28 8 0 7 0 0
1 2 030 0
% Infected: 0.0% 50.0% 0.0% Total: 0
vUL47-eGFP +
vUL47-mRFP
28 10 3 9 2 1
9 360 0
1 2 030 0
1 0 450 0
% Infected: 24.4% 56.1% 4.9% Total: 1
aChickens were inoculated with 2,000 PFU of vUL47-eGFP or vUL47-mRFP, or with a mixture of 1,000 PFU of vUL47-eGFP and vUL47-mRFP each at 7 days of age.
bSkin samples were collected at 28 days post-inoculation (p.i.).
cThe number of follicles examined for each chicken.
dThe number of follicles positive for green fluorescence (vUL47-eGFP replication) and percent follicles infected per group.
eThe number of follicles positive for red fluorescence (vUL47-mRFP replication) and percent follicles infected per group.
fThe number of follicles positive for both green and red fluorescence and percent follicles infected with both viruses per group.
gThe number of regions within follicles that were positive for both green and red fluorescence and the total per group.
doi:10.1371/journal.pone.0037428.t002
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within a time interval of 2 to 8 h allowed the establishment of
superinfection inhibition. It has not been demonstrated that
superinfection inhibition occurs at the cellular level in the host
during infection with homologous alphaherpesviruses, but the data
presented in this report suggests that superinfection inhibition
occurs during in the natural host during alphaherpesvirus
infections (Fig. 3, 4, 5). These studies cannot exclude that FFE
cells infected with one virus were not also infected with the second,
but the level of fluorescent protein expressed by the second virus
was below the level of detection in this system. Further studies are
needed to determine if viral genomes of the second virus are
present and are the focus of ongoing research.
It is not clear why both superinfection inhibition and dual
infection can co-occur within the host, but most likely each event is
dependent on the point at which the cell is infected. That is, dual
infection is mostly dependent on the cell becoming infected at
relatively the same time with both viruses, whereas superinfection
inhibition is most likely due to infection of the cell with one virus
and after a certain length of time, perhaps .4 h as previous in vitro
studies might suggest [17,41], the cell is refractory to infection with
the second virus. It is not possible to synchronize infection of the
FFE cells with MDV in this natural virus-host system; therefore
the time of infection of each FFE cell would most likely be a
stochastic process. Figure 7 summarizes potential scenarios in
which dual infection of cells and superinfection inhibition would
occur in the feather follicles of infected chickens with MDV.
It was interesting that in both superinfection experiments
(Tables S1 and S2); active replication of the second virus was not
seen in the FFE cells examined. As mentioned above, infection of
FFE cells by MDV may be dependent upon circulating infected T
cells transferring virus to these cells; therefore the lack of visual
evidence of the second inoculated virus replicating in FFE cells
could be merely due to a robust immune response to the first
inoculated virus. Still, it seemed surprising that no visual evidence
of replication of the second virus could be seen in the tissues
examined since it is has been established that superinfection of
chickens with MDV and MD-vaccine strains does occur with
regularity, leading to shedding of both viruses [42,43]. This would
require that infection and replication in the FFE cells must occur
in superinfected chickens.
The results presented here are consistent with a recent report
evaluating superinfection of chickens with two different virulent
MDVs using short- and long-intervals between the first and second
inoculations [44]. In this report, Dunn et al. also found that in
long-interval experiments (13 days between inoculations), evidence
of the second inoculated virus was present in only ,5% of the
samples tested compared to ,55% in short-interval experiments (1
day between inoculations) using highly sensitive pyrosequencing
analysis of skin tissues for each virus. However, their method of
analysis would not discriminate between latently infected T cells
Table 3. Coinfection with attenuated and virulent viruses (Experiment 4).
Group
a
Analysis (days
p.i.)
b Follicles (n)
c Green
d Red
e Coinfection Follicle
f Dual infection Cell
g
vDRLORF4-47mRFP 21 23 0 16 0 0
% Infected: 0.0% 69.6% 0.0% Total: 0
vDRLORF4-47mRFP 28 46 0 14 0 0
% Infected: 0.0% 30.4% 0.0% Total: 0
vUL47-eGFP 21 31 7 0 0 0
% Infected: 22.6% 0.0% 0.0% Total: 0
vUL47-eGFP 28 50 39 0 0 0
% Infected: 78.0% 0.0% 0.0% Total: 0
vDRLORF4-47mRFP +
vUL47-eGFP
21 31 9 14 5 2
3 5 370 0
36 18 19 9 4
3 8 040 0
% Infected: 21.4% 31.4% 10.0% Total: 6
vDRLORF4-47mRFP +
vUL47-eGFP
28 57 45 16 9 3
61 36 28 19 1
52 32 24 14 4
34 16 8 3 2
% Infected: 63.2% 37.3% 22.1% Total: 10
aChickens were inoculated with 2,000 PFU of vDRLORF4-47mRFP or vUL47-eGFP, or with a mixture of 1,000 PFU of vDRLORF4-47mRFP and vUL47-eGFP each at 7 days
of age.
bSkin samples were collected either 21 or 28 days post-inoculation (p.i.).
cThe number of follicles examined for each chicken.
dThe number of follicles positive for green fluorescence (vUL47-eGFP replication) and percent follicles infected per group.
doi:10.1371/journal.pone.0037428.t003
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shown in the present study. Though it is difficult to compare the
two studies as they used different time points for inoculation and
analysis, and different sampling techniques, their data would be
consistent with the information presented here and would indicate
that a robust immune response against the first inoculated virus
most likely explains the lack of replication of the second virus in
these experiments. In support of this are data shown in experiment
3 (Table S2) in which the first inoculated virus, highly attenuated
vAU5-47mRFP, was barely detected in the feather follicles, yet
Figure 3. Summary of coinfected feather follicles and dually infected FFE cells at low magnification. Skin/feather tissues were collected
from chickens coinfected with vUL47-eGFP and vUL47mRFP (A and B) and sectioned either transversely through the follicle (A) or longitudinally down
the follicle (B). Tissues were fixed, stained with Hoechst 33342 to visual nuclei, and examined using an Axio Imager M1 system at 625 (A and B).
Feathers were plucked from the wing of a chicken coinfected with DRLORF4-47mRFP and vUL47-eGFP and examined directly for fluorescence using
an Olympus SZX-12 Stereoscope at 65 (C). Arrowheads (b) indicate regions where only vUL47-eGFP replication is evident, open arrowheads (,)
indicate regions where only vUL47-mRFP (A and B) or vDRLORF4-47mRFP (C) replication are evident, while asterisks (*) indicate regions where both
vUL47-eGFP and vUL47-mRFP or vUL47-eGFP and vDRLORF4-47mRFP are replicating. Feather follicles (FF) are indicated.
doi:10.1371/journal.pone.0037428.g003
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37428Figure 4. Summary of coinfected feather follicles and dual infected FFE cells at high magnification. Skin/feather tissues were collected
from chickens coinfected with vUL47-eGFP and vUL47mRFP and examined using an SP5 LSCM system from Leica Microsystems, Inc. at6200 (A, top
panel) or 6400 (A, bottom panel and B). Hoechst 33342 stain was used to stain nuclei (blue). Single Z-stack images are shown with the depth
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was also not seen in all but one chicken. This chicken was negative
for the presence of vAU4-47mRFP in the feather follicles. The
parent virus, vAU5 vTR, was previously tested as a vaccine
candidate and protected animals against a lethal challenge [37];
therefore this would suggest that a potent immune response to
vAU5-47mRFP prevented efficient superinfection by vUL47-
eGFP and was not dependent on vAU5-47mRFP infecting feather
follicles and inhibiting superinfection with vUL4-eGFP.
It has been presumed that different MDV strains, or related
avian herpesviruses like MeHV-1, could infect the same feather
follicles since superinfection of chickens with different herpesvi-
ruses has been documented for many years. However, previous
work could not determine whether infected feather follicles were
refractory to coinfection or superinfection with a second virus. For
example, it is well known that vaccination of chickens with
attenuated MDV, non-oncogenic GaHV-3, or non-oncogenic
MeHV-1 does not prevent superinfection of the animal, and,
subsequently, transmission of pathogenic MDV [3,31,45]. There
appeared to be at least three scenarios that previous studies
examining replication of MDV in feather follicles and superinfec-
tion could not discriminate. First, both viruses could readily
replicate in the skin, but each virus replicates in separate feather
follicles and are refractory to coinfection or superinfection of the
same feather follicle (superinfection inhibition of the feather
follicle). Second, both viruses could infect the same follicles, but
could not dually infect the same cells within that follicle
(superinfection inhibition of the cell). Third, both viruses can
infect the same cells within a feather follicle (dual infection of the
cell).
Based on the data presented here, the first scenario described is
incorrect as many feather follicles clearly contain both viruses
actively replicating within an individual feather follicle (Fig. 3, 4, 5,
6 and S5). Therefore, there is no evidence for a refractory
mechanism of a feather follicle infected with a single virus.
However, it does appear that a combination of the remaining two
scenarios do co-occur with some regularity. Individual cells or
areas infected with a single virus may be refractory to infection
and/or replication of the second virus. This is most evident in
Figures 3A, 4A, and 5, in which one virus is replicating in a group
indicated in the upper left of each image. Arrowheads (b), open arrowheads (,), and asterisks (*) indicate single and dual infected cells as in Fig. 2.
Superinfection inhibition can be seen in (A), while dual infection of FFE cells with both viruses replicating can be seen in (B). Feather follicles (FF) are
indicated.
doi:10.1371/journal.pone.0037428.g004
Figure 5. Superinfection inhibition in FFE cells by rMDV. Skin/feather tissues collected from chickens coinfected with vDRLORF4-mRFP and
vUL47-eGFP were examined using an Axio Imager M1 system at 625. Regions where only vUL47-eGFP is replicating next to cells where only
vDRLORF4-mRFP were traced using Adobe Photoshop and transferred to the accompanying single color image to better show the distinct separation
of colors. Feather follicles (FF) are indicated.
doi:10.1371/journal.pone.0037428.g005
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replication of both viruses does not overlap. This observation is not
unique and could be seen with regularity in coinfected follicles.
Clear evidence also exists for dual infection of single cells by both
viruses as can be seen in Figures 3A, 4B, 6, and S5. Therefore,
within the animal, dual infection of individual cells and
superinfection inhibition can co-occur during alphaherpesvirus
infection in vivo.
The mechanism by which MDV has become more virulent is
not known, but homologous recombination with similar avian
herpesviruses could play a role. To date, it has not been
demonstrated that homologous recombination between MD
vaccines and pathogenic MDV has occurred. This is partly due
Figure 6. Dual infection of FFE cells with two rMDVs. Skin/feather tissues collected from chickens coinfected with vDRLORF4-mRFP and vUL47-
eGFP in experiment 4 were examined using an SP5 LSCM system from Leica Microsystems, Inc at 61,890. Cells shown in this Z-stack image are
replicating both virus as evidence by expression both UL47-eGFP and UL47-mRFP. The top two panels are green and red images alone, while the
bottom panel is the merged image of red and green with Hoechst 33342 (blue) staining of nuclei for contrast. The cells infected with both viruses are
indicated with an asterisk (*).
doi:10.1371/journal.pone.0037428.g006
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major technological advances in the last decade now allow those
types of studies. With respect to VZV, it has been shown that
recombination between the live varricella vaccine and wild-type
VZV occurs during coinfection in vitro [46] and has been suggested
to occur in vivo [47]. Most recently, Breuer and colleagues [39]
referred to the emergence of new wild-type/vaccine recombinants
by partial-genome sequencing of VZV isolates. The monitoring of
VZV genomes since the introduction of vaccines has just begun,
but it has been suggested that the frequency of recombinant
viruses has mostly likely been underestimated in the past and will
increase in coming decades for VZV [48]. The similarities
between MDV and VZV with respect to entry into, and exit
from, the host are striking as both enter through the respiratory
tract, systemically infect T cells that then travel to the skin and
transfer virus to epithelial cells, whereupon infectious virus is shed
into the environment. In support of these similarities, two
homologous genes in both viruses, namely glycoprotein C (MDV
UL44, VZV ORF14) and a conserved herpesviral protein kinase
(MDV UL13, VZV ORF47) have critical roles during replication
in the skin [49,50] and for transmission [51,52]. The history of
vaccination against MD in chickens with homologous alphaher-
pesviruses that do not prevent superinfection, and the increasing
virulence of MDV over the decades due to vaccination, combined
with the definitive proof here that two alphaherpesviruses can
dually infect the same cells, should be taken into consideration
when designing the next generation of vaccines against MD in
chickens and varicella/herpes zoster in humans.
Figure 7. Hypothetical model for coinfection of the host at the organism and cellular level using the chicken as a natural host. (A)
During natural infection of chickens previously vaccinated against Marek’s disease, pathogenic (P) MDV enters the chicken through the respiratory
route. After entering the host, MDV infects T cells that can then transfer the virus to specialized FFE cells in the skin where infectious virus is produced
and shed into the environment and continuing the virus life cycle. Although vaccination with vaccine virus (V) protects chickens from the
development of disease, pathogenic MDV can infect and replicate within FFE cells (see below). Should two different pathogenic or a pathogenic and
vaccine viruses replicate within the same cell; homologous recombination between the viruses could occur leading to recombinant virus (R). Each
virus replicating within the chicken can then be shed into the environment where natural selection will select for traits that benefit the virus. (B)
Fluorescence microscopy of feather follicles infected with two similar, but distinguishable viruses expressing either eGFP or mRFP. (C) Schematic
diagram of potential scenarios during infection of feather follicles by two MDVs. 1) Pathogenic (shown) or vaccine virus could infect FFE cells and
travel along the feather follicle (FF) infecting more FFE cells until the cells and virus are shed from the chicken with no interference from other viruses.
2) Prior infection of FFE cells by the vaccine virus could induce superinfection inhibition within the infected cell, thereby blocking dual infection of the
FFE cell by circulating T cells in the skin. 3) Vaccine virus has already infected FFE cells, but pathogenic virus could be transferred from an infected T
cell to a newly vaccine infected FFE cell prior to the induction of superinfection inhibition such that both viruses could infect the same FFE cell. This
could lead to dual infection of the cell and the generation of recombinant virus (R). 4) Both vaccine and pathogenic viruses circulating within the skin
could transfer virus to the same FFE cell at approximately the same time and dually infecting the cell. Again, this could potentiate exchange of
genetic material between the viruses generating recombinant virus (R). 5) It is also possible that both vaccine and pathogenic viruses could have
dually infected T cells prior to transfer to FFE cells, though the studies presented here do not evaluate this possibility. 6) It is also possible that a virus
could be transferred from an infected T cell to FFE cells and as the virus replicates and presumably travels along the FFE tract, encounters cells that
have previously been infected with vaccine virus, thereby blocking dual infection. In this scenario, it would be expected the pathogenic virus infects a
different group of cells along the FFE tract or replication ceases in these cells. In all scenarios, the final output virus generated and shed would
ultimately undergo natural selection for increased virulence.
doi:10.1371/journal.pone.0037428.g007
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Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of Cornell University (permit number 2008-0018).
The animal care facilities and programs of Cornell University
meet the requirements of the law (89-544, 91-579, 94-276) and
NIH regulations on laboratory animals, and are in compliance
with the Animal Welfare Act, PL 279. All experimental procedures
were in compliance with approval of Cornell University’s
Institutional Animal Care and Use Committee and all efforts
were made to minimize suffering.
Cell Cultures and Viruses
Chicken embryo cell cultures were prepared from 10-day-old
specific-pathogen-free (SPF) embryos following standard methods
[53], and used to reconstitute viruses from pRB-1B DNA. CKC
cultures were prepared from 14 day old SPF chickens [53] and
used to propagate parental and recombinant viruses. All recon-
stituted BAC clones were used at #5 passages.
Generation of UL47-tagged Clones
Recombinants with eGFP or mRFP inserted in frame at the C-
terminus of UL47 were generated using infectious BAC clones of
the RB-1B strain [51] using two-step Red-mediated mutagenesis.
vUL47-eGFP was generated and characterized previously [33],
while vUL47-mRFP was generated for this report. To generate
attenuated rMDV expressing UL47-mRFP, two previously char-
acterized attenuated rMDV BAC clones were used. First,
DRLORF4, in which both copies of RLORF4 were deleted, has
been shown to exhibit attenuated characteristics with increased
replication in vitro and decreased replication and disease incidence
in vivo [36]. A second mutant, AU5 vTR, in which both copies of
the viral telomerase RNA (vTR) template sequences were mutated
(vTR AU5) was also used [37]. This virus replicates like wild-type
virus in vitro, but is attenuated in vivo exhibiting decreased
replication levels and abrogation of tumorigenesis.
Briefly, the mRFP-I-SceI-aphAI cassette was amplified from pEP-
mRFP-in and used for the mutagenesis of each recombinant
clones in GS1783 Escherichia coli cells as described previously [51].
Mutagenesis primers were as follows: UL47mRFP Forward: 59-
gccgtcgaaaccgcccgccgtgagccacaacgggcgaatatggcctcctccgaggacg
- 39 and UL47mRFP Reverse: 59 - acatccggag-
taaaagtcccgccctcttccctacgtcacaaggcgccggtggagtg - 39 (under-
lined = UL47 specific sequences, bold = pEP-mRFP-in specific
sequences). All recombinant clones were confirmed by restriction
fragment length polymorphism (RFLP), PCR, and DNA sequenc-
ing.
rMDVs were reconstituted by transfecting chick embryo cell
cultures with purified BAC DNA using the CaPO4 precipitation
method [54] with a plasmid expressing the Cre enzyme (pCAGGS-
NLS/Cre) for excision of mini-F sequences using loxP sites and
screened as previously described [51]. See Figure 1 and Table 1
for more detailed description of the viruses used in this study.
Measurement of Plaque Areas
Plaque areas were measured exactly as previously described
[33]. Plaque areas were measured using ImageJ [55] version 1.41o
software (rsb.info.nih.gov/ij) and means were determined for each
virus. Significant differences in mean plaque areas were deter-
mined using Student’s t tests.
Fluorescence Microscopy
CKC cultures were infected with vUL47-eGFP, vUL47-mRFP,
vDRLORF4-47mRFP, or vAU5-47mRFP on sterile glass cover-
slips in 24-well dishes at 50 PFU per well. At 5 days p.i., cells were
fixed with PFA buffer (2% paraformaldehyde, 0.1% Triton X-100)
for 15 min and then washed twice with phosphate-buffered saline.
Skin/feather tissues were collected from the ventral feather tracts
of rMDV-infected chickens in 15610 mm sections and snap-
frozen in Tissue TekH-optimal cutting temperature (OCT)
compound (SankuraH Finetek, Torrance, CA) and stored at -
80uC until sectioned. Eight mm sections were affixed to Super-
frost/Plus slides (Fisher Scientific, Pittsburgh, PA) and fixed as
described above. Primary flight feathers were plucked from the left
wing of rMDV-infected chickens and immediately viewed with a
stereoscope.
Infected CKC cultures and cryosectioned tissues used for
antigen detection were blocked in 10% neonatal calf serum,
stained with monoclonal antibody O11 directed against the early
lytic MDV protein pp38 [56] or chicken anti-MDV antiserum
[36]. Goat anti-mouse IgG-Alexa FluorH 488 or 568 and goat anti-
chicken IgY-Alexa FluorH 488 or 568 (Molecular Probes, Eugene,
OR) were used as secondary antibodies. Hoechst 33342 (2 mg/ml,
Molecular Probes) was used to visualize nuclei. An Axio Imager
M1 system with AxioVision software (Carl Zeiss, Inc., Thorn-
wood, NY) or a Leica Microsystems, Inc. (Buffalo Grove, IL) SP5
LSCM system was used to analyze stained coverslips or slides. The
following fluorescent dyes were excited and emissions detected
with the SP5 LCSM as follows: Hoechst 33343 excited at 405 nm
with a UV diode laser and detected at 417–462 nm; eGFP and
Alexa FluorH 488 excited with an Argon laser (458 nm laser line)
and detected at 498-550 nm; mRFP and Alexa FluorH 568 excited
at 561 nm with a Diode-pump Solid State (DPSS) laser and
detected at 566-632 nm. The Olympus SZX-12 Stereoscope
(kindly provided by the Plant Cell Imaging Center at The Boyce
Thompson Institute for Plant Research, Ithaca, NY) was used for
analysis of whole skin/feather and plucked feathers at low
magnification. The long pass (LP) Green (excitation 470 nm,
emission LP 500 nm) and Red (excitation 540 nm, emission
605 nm) filter cubes were used to detect eGFP and mRFP,
respectively. All images were compiled using AdobeH PhotoshopH
CS2 version 9.0.2.
Animal Studies
SPF P2a (MHC: B
19B
19) chickens were obtained from
departmental flocks and housed in isolation units. Water and food
were provided ad libitum. Chickens were inoculated intra-abdom-
inally with 1,000 or 2,000 PFU of each virus at various times
dependent on the experiment. Virus inocula consisted of rMDV-
infected CKC cultures. For coinfection experiments, virus inocula
were mixed prior to injection into chickens. Chickens were
assigned to inoculation groups using a randomization table.
Supporting Information
Figure S1 Plaque area assays of rMDV. Plaque areas were
measured for viruses reconstituted from rParental (vParental),
rUL47-eGFP (vUL47-eGFP), rUL47-mRFP (vUL47-mRFP),
rDRLORF4 (vDRLORF4), rDRLORF4-47mRFP (vDRLORF4-
47mRFP), rAU5 (vAU5), and rAU5-47mRFP (vAU5-47mRFP).
Error bars represent standard error of the means for each group (n
=30). Both DRLORF4 viruses induced plaques that were
significantly different (vDRLORF4, P =7.3610
26;v DRLORF4-
47mRFP, P =2.4610
25) from vParental using Student’s t tests
and are indicated with an asterisk (*).
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Figure S2 Expression of UL47-eGFP and UL47-mRFP
fusion proteins in vitro. CKC cultures were infected with
vParental, vUL47-eGFP, vUL47-mRFP, vDRLORF4-47mRFP,
or vAU5-47mRFP on glass coverslips and then fixed at 4 days p.i.
An anti-MDV chicken antibody was used to identify overall MDV
antigen expression with goat anti-chicken IgG-Alexa FluorH 568
(A) or 488 (B) secondary antibody, and Hoechst 33342 was used to
identify nuclei (blue). For each plaque, the same parameters (lasers,
excitation/emission wavelengths, time of exposure, magnification,
etc.) were used to compare the fluorescence intensities. Merged
images contain all three fluorescent channels. Images were
recorded at 6100 magnification using an Axio Imager M1 system
with AxioVision software and compiled using Adobe Photoshop.
(TIF)
Figure S3 Tumor induction by rMDVs. Tumor incidence
was determined over the course of 56 days in chickens infected
with vUL47-eGFP, vUL47-mRFP, vDRLORF4-47mRFP, or
vAU5-47mRFP (n =18 to 20). Chickens were evaluated daily
for clinical signs of MD, euthanized when symptoms were
apparent, and necropsies were performed to identify tumor
lesions. As expected, both vUL47-eGFP and -mRFP were highly
virulent [33], while vDRLORF4-47mRFP was highly attenuated
and vAU5-47mRFP was completely non-oncogenic, as previously
described for both [36,37].
(TIF)
Figure S4 Experimental design for coinfection and
superinfection of chickens with different rMDVs. Four
experiments were designed to coinfect (A and D) or superinfect (B
and C) chickens with different fluorescently-tagged UL47 rMDVs.
(TIF)
Figure S5 Multiple Z-stack images of FFE cells dually
infected with two rMDVs. A total of 50 Z-stack images were
collected from this tissue to view the replication of vDRLORF4-
47mRFP and vUL47-eGFP through an 8 mm section. Only shown
are every ten Z-stack images, excluding the last image that was
negative for both colors. Both viruses can be seen replicating in the
same cells throughout the Z-stacks.
(TIF)
Table S1 Superinfection with virulent viruses (Experi-
ment 2) to observe dual infection of feather follicle
epithelial cells.
(DOC)
Table S2 Superinfection with attenuated and virulent
viruses (Experiment 3) to observe dual infection of
feather follicle epithelial cells.
(DOC)
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